Skip to content

Clinical trials

Phase 1/2 Ovarian Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20051
20091
20101
20121
20142
20192
20201
20211
20221
20233
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10
Completed5
Unknown status2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AGO Study Group2
AstraZeneca2
Eli Lilly and Company2
Aprea Therapeutics1
BioNTech SE1
Bristol-Myers Squibb1
Clovis Oncology, Inc.1
Daiichi Sankyo1
Genzyme, a Sanofi Company1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms19
Endometrial Neoplasms8
Uterine Cervical Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Colorectal Neoplasms4
Fallopian Tube Neoplasms4
Breast Neoplasms3
Melanoma3
Neoplasms3
Recurrence3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.